[Federal Register Volume 68, Number 52 (Tuesday, March 18, 2003)]
[Notices]
[Pages 12911-12912]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-6397]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of certain FDA advisory committees by the Commissioner of Food 
and Drugs (the Commissioner). The Commissioner has determined that it 
is in the public interest to renew the charters of the committees 
listed in the following table for an additional 2 years beyond charter 
expiration date. The new charters will be in effect until the dates of 
expiration listed in the following table. This notice is issued under 
the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-
463 (5 U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates 
indicated in the following table unless the Commissioner formally 
determines that renewal is in the public interest.

------------------------------------------------------------------------
         Name of committee                    Date of expiration
------------------------------------------------------------------------
Science Board to the Food and Drug   June 26, 2004
 Administration
Allergenic Products Advisory         July 9, 2004
 Committee
Cardiovascular Drugs Advisory        August 27, 2004
 Committee
Endocrinologic and Metabolic Drugs   August 27, 2004
 Advisory Committee
Oncologic Drugs Advisory Committee   September 1, 2004
Anti-Infective Drugs Advisory        October 7, 2004
 Committee
Dermatologic and Ophthalmic Drugs    October 7, 2004
 Advisory Committee
Biological Response Modifiers        October 28, 2004
 Advisory Committee
Technical Electronic Product         December 24, 2004
 Radiation Safety Standards
 Committee
Antiviral Drugs Advisory Committee   February 15, 2005
------------------------------------------------------------------------


[[Page 12912]]


FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    Dated: March 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-6397 Filed 3-17-03; 8:45 am]
BILLING CODE 4160-01-S